Left ventricular function in atrial fibrillation during overdrive pacing

American Heart Journal

Volumn 143, Issue 5, 2002, Pages 827-832

  Vankawala, Viren ^a   Markabawi, Bashar ^a   Dainiak, Sara ^a   Werner, Morgan ^a   Hager, W David ^a   Farrel, William ^a   Katz, Arnold M ^a   Silverman, David I ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA VALVE; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART PACING; HEART STROKE VOLUME; HUMAN; PRIORITY JOURNAL;

EID: 0036272002     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.121272     Document Type: Article

References (39)

1. Prognostic significance of atrial fibrillation in congestive heart failure
2. Impact of atrial fibrillation on mortality, stroke, and medical costs
3. Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial
4. Antiarrhythmic drug therapy in the treatment of atrial fibrillation
5. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation
6. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation
7. Proarrhythmic effects of the new antiarrhythmic flecainide acetate
8. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized controlled trials
9. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
10. Influence of left ventricular dysfunction on flecainide therapy
11. The cardiac arrhythmia suppression trial (CAST)
12. Atrial fibrillation follow-up investigation of rhythm management: The AFFIRM study design
13. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation
14. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation
15. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation
16. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response
17. Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing
18. Relationship between beat-to-beat changes in hemodynamic state and action potential duration of the left ventricle during rapid ventricular pacing in man
19. Effect of ventricular pacing on left ventricular function assessed by radionuclide angiography
20. The hemodynamic effects of ventricular pacing with and without atrioventricular synchrony in patients with normal and diminished left ventricular function
21. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements
22. Cardiac performance early after cardioversion from atrial fibrillation
23. Interval-dependent changes in left ventricular contractile state in lone atrial fibrillation and in atrial fibrillation associated with coronary artery disease
24. Loss of adrenergic control of the force-frequency relation in heart failure secondary to idiopathic or ischemic cardiomyopathy
25. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy
26. Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation
27. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: A randomized controlled study
28. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response
29. Ablate and pace for drug refractory paroxysmal atrial fibrillation. Is ablation necessary?
30. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation
31. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation
32. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation
33. DDD(R) pacing with automatic mode switch in patients with paroxysmal atrial fibrillation following AV nodal ablation
34. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: Effects of pacing mode and mode-switch olgorithm
35. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation
36. Atrial pacing in the prevention of paroxysmal atrial fibrillation: First results of a new combined algorithm
37. Multi-site atrial pacing: An option for atrial fibrillation prevention? Preliminary results of the Dutch dual-site right atrial pacing for prevention of atrial fibrillation study
38. Pacing to prevent atrial fibrillation
39. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block